Research Article
Clinical Features of Primary and Systemic Metastatic Intraocular Lymphomas in Spanish Patients
Table 2
Contribution of diagnostic techniques according to final diagnosis and type of specimen in intraocular lymphomas.
| Patient | Final diagnosis | Sample | Pathological diagnosis | IHC contributory | FC contributory |
| 1 | PIOL T | Vitreous | Suspicious | No | NP | 2 | PIOL DLBCL | Vitreous | Lymphoma | NP | NP | 3 | PIOL DLBCL | Vitreous | Lymphoma | Yes | No | 3 | PIOL DLBCL | Vitreous | Lymphoma | Yes | NP | 4 | PIOL DLBCL | Aqueous | Lymphoma | Yes | Yes | 5 | PIOL DLBCL | Vitreous | Lymphoma | Yes | NP | 6 | PIOL DLBCL | Vitreous | Lymphoma | Yes | NP | 7 | PIOL DLBCL | Enucleation | Lymphoma | Yes | NP | 8 | PIOL DLBCL | Vitreous | Lymphoma | Yes | NP | 8 | PIOL DLBCL | Vitreous | Lymphoma | Yes | Yes | 9 | PIOL DLBCL | Vitreous | Lymphoma | Yes | Yes | 10 | SIOL T-NK | Vitreous | Lymphoma | Yes | Yes | 11 | SIOL DLBCL | Vitreous | Negative | NP | NP | 11 | SIOL DLBCL | Subretinal aspirate | Lymphoma | Yes | NP | 11 | SIOL DLBCL | Retinal biopsy | Lymphoma | Yes | NP | 12 | SIOL DLBCL | Aqueous | Suspicious | Yes | NP | 13 | SIOL DLBCL | Vitreous | Negative | NP | No | 13 | SIOL DLBCL | Vitreous | Lymphoma | Yes | Yes | 14 | SIOL DLBCL | Vitreous | Lymphoma | Yes | Yes | 15 | SIOL DLBCL | Vitreous | Suspicious | No | No | 15 | SIOL DLBCL | Retinal biopsy | Lymphoma | Yes | NP | 16 | PIOL MALT B | Teno-Conjuntival biopsy | Lymphoma | Yes | NP | 17 | PIOL MALT B | Teno-Conjuntival biopsy | Lymphoma | Yes | No | 18 | PIOL MALT B | Iris biopsy | Lymphoma | Yes | Yes | 19 | PIOL MALT B | Teno-Conjuntival biopsy | Lymphoma | Yes | NP |
|
|
PIOL, primary intraocular lymphoma; SIOL, secondary intraocular lymphoma; DLBCL, diffuse large B-cell lymphoma; NK, natural killer; MALT B, mucosa-associated lymphoid tissue B-cell lymphoma; IHC, inmunohistochemistry; FC, flow cytometry; NP, not performed.
|